SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
1-Year Return
0.41%
This Quarter Return
+6.7%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$467M
AUM Growth
+$4.66M
(+1%)
Cap. Flow
-$18.4M
Cap. Flow
% of AUM
-3.94%
Top 10 Holdings %
Top 10 Hldgs %
35.86%
Holding
100
New
18
Increased
16
Reduced
23
Closed
17
Top Buys
| 1 |
Praxis Precision Medicines
PRAX
|
$10.1M |
| 2 |
Nova
NVMI
|
$8.21M |
| 3 |
SHLT
SHL Telemedicine Ltd American Depositary Shares
SHLT
|
$7.96M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
$7.6M |
| 5 |
Day One Biopharmaceuticals
DAWN
|
$6.33M |
Top Sells
| 1 |
Nutrien
NTR
|
$10.7M |
| 2 |
Invesco QQQ Trust
QQQ
|
$8.46M |
| 3 |
Eli Lilly
LLY
|
$7.5M |
| 4 |
Teva Pharmaceuticals
TEVA
|
$7.45M |
| 5 |
Microsoft
MSFT
|
$6.92M |
Sector Composition
| 1 | Healthcare | 78.63% |
| 2 | Technology | 13.25% |
| 3 | Consumer Discretionary | 3.47% |
| 4 | Utilities | 0.8% |
| 5 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
GSK
GSK
$79.3B
| $3.56M | 0.56% |
+100,000
| New | +$3.56M |
|
52
Travere Therapeutics
TVTX
$1.81B
| $3.28M | 0.51% |
213,462
+25,962
| +14% | +$399K |
|
53
Gilead Sciences
GILD
$140B
| $3.08M | 0.48% |
+40,000
| New | +$3.08M |
|
54
89bio
ETNB
$1.26B
| $2.56M | 0.4% |
+135,000
| New | +$2.56M |
|
55
Arcellx
ACLX
$3.93B
| $2.45M | 0.38% |
77,488
-90,000
| -54% | -$2.85M |
|
56
Rezolute
RZLT
$632M
| $2.29M | 0.36% |
1,155,897
| – | – |
|
57
Cartesian Therapeutics
RNAC
$259M
| $2.28M | 0.36% |
67,950
-9,550
| -12% | -$321K |
|
58
Amylyx Pharmaceuticals
AMLX
$879M
| $2.16M | 0.34% |
+100,000
| New | +$2.16M |
|
|
ALPN
59
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $2.06M | 0.32% |
200,000
| – | – |
|
60
Werewolf Therapeutics
HOWL
$61.3M
| $1.91M | 0.3% |
626,810
| – | – |
|
61
Altimmune
ALT
$316M
| $1.77M | 0.28% |
500,000
+200,000
| +67% | +$706K |
|
62
uniQure
QURE
$945M
| $1.7M | 0.27% |
148,734
+86,734
| +140% | +$994K |
|
63
Vera Therapeutics
VERA
$1.4B
| $1.69M | 0.26% |
+105,000
| New | +$1.69M |
|
64
Rigel Pharmaceuticals
RIGL
$724M
| $1.58M | 0.25% |
122,813
-65,072
| -35% | -$839K |
|
65
Compugen
CGEN
$130M
| $1.4M | 0.22% |
+1,229,808
| New | +$1.4M |
|
66
Mersana Therapeutics
MRSN
$34.7M
| $1.38M | 0.22% |
16,742
+16,317
| +3,839% | +$1.34M |
|
|
ELEV
67
DELISTED
Elevation Oncology
ELEV
| $1.37M | 0.21% |
+900,000
| New | +$1.37M |
|
68
Dyne Therapeutics
DYN
$1.86B
| $1.35M | 0.21% |
119,918
-99,398
| -45% | -$1.12M |
|
|
INBX
69
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $1.3M | 0.2% |
+50,000
| New | +$1.3M |
|
70
MediWound
MDWD
$182M
| $1.18M | 0.19% |
111,127
| – | – |
|
71
PMV Pharmaceuticals
PMVP
$76.8M
| $1.18M | 0.18% |
187,800
| – | – |
|
|
IMTXW
72
DELISTED
Immatics N.V. Warrants
IMTXW
| $342K | 0.05% |
100,000
| – | – |
|
|
INFI
73
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $311K | 0.05% |
1,476,000
| – | – |
|
74
Cyclacel Pharmaceuticals
CYCC
$16.4M
| $147K | 0.02% |
69
| – | – |
|
75
Arbe Robotics
ARBE
$134M
| $125K | 0.02% |
43,165
| – | – |
|